Absci Doses First Participants in Phase 1 Trial of AI-Designed Antibody for IBD
Absci has announced the dosing of the first participants in a Phase 1 trial of ABS-101, an investigational antibody for …
All Posts
Eligo Bioscience Gets $5M Grant to Advance Gene-Editing Skin Therapy Using Bacteria
The funding supports development of Eligo’s topical gene delivery system, which programs skin-resident bacteria to locally produce therapeutic biologics.
Kvantify Taps Gefion AI Supercomputer to Scale Quantum Chemistry Simulations for Drug Discovery
As reported by The Quantum Insider, Kvantify, a Denmark-based quantum software firm focused on chemistry and drug discovery, has become …
Dutch Startup CryoCloud Lands €2M to Automate Cryo-EM for Drug Discovery
Dutch startup CryoCloud, a provider of cloud-native tools for cryo-electron microscopy (cryo-EM) data analysis, has raised €2M in seed funding …
Valinor Discovery Launches to Simulate Drug Efficacy in Virtual Patients
Valinor Discovery, a San Francisco-based startup, has launched from stealth to build generative machine learning models that simulate how patients may …
Lantern Pharma Gets FDA Green Light for AI-Guided Trial Targeting Hard-to-Treat Lung Cancer
The company’s second Phase 1b/2 trial of LP-184 within a month will test the AI-developed small molecule in patients with …
OpenAI Introduces Open Benchmark To Assess AI Performance in Realistic Healthcare Scenarios
OpenAI has released HealthBench, an open-source benchmark developed with 262 physicians across 60 countries to evaluate large language models (LLMs) in …
AI Drug Discovery Company Insilico Medicine Makes Third Bid for Hong Kong IPO
Insilico Medicine has filed again for an IPO on the Hong Kong Stock Exchange (HKEX), marking its third attempt following …
Toronto’s Intrepid Labs Emerges with $11M and AI-Driven Platform to Rebuild Drug Formulation R&D
Toronto-based Intrepid Labs has emerged from stealth with $11 million in total funding to commercialize its autonomous drug formulation platform, …
Scientists Engineer Precision Tool for Mitochondrial DNA Manipulation
A research team at Fujita Health University has developed a precision genome-editing approach to modulate levels of mutant mitochondrial DNA …
Khondrion Secures €5M to Advance Small Molecule Therapy Toward Phase 3 Trial
Khondrion, a clinical-stage biotech company focused on primary mitochondrial disease (PMD), has secured up to €5M in Innovation Credit from …
Iktos Brings its Gen-AI Drug Design Platform to AWS Marketplace
Iktos, a company developing AI and robotic technologies for medicinal chemistry and small molecule drug design, has expanded its collaboration …